Efficacy of a Flavo-Proxylane Skincare Protocol Before and After Ultrasound Treatment in Patients Receiving Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy - Top-Institutions - MDSpire

Efficacy of a Flavo-Proxylane Skincare Protocol Before and After Ultrasound Treatment in Patients Receiving Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy

  • By

  • Amir Moradi

  • Jihee H. Kim

  • Jemin M. Kim

  • Hina N. Choudhary

  • Patricia M. Brieva

  • March 4, 2026

  • 0 min

Share

Top Institutions in Dermatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Metabolic Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Clinical Research

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Biomedical Engineering

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Dermatology
    • Endocrinology
    • Clinical Trials

Original Source(s)

Efficacy of a Flavo-Proxylane Skincare Protocol Before and After Ultrasound Treatment in Patients Receiving Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Therapy

  • by Amir Moradi, Jihee H. Kim, Jemin M. Kim, Hina N. Choudhary, Patricia M. Brieva

  • March 4, 2026

Related Content

Dermatological Toxicities Associated with Targeted Cancer Therapies: An In-Depth Analysis of Mechanisms, Treatment Strategies, and Existing Research Gaps—A Narrative Review

Teledermatology in Community Settings for Prompt Evaluation of Suspected Skin Cancer: A Cost-Effectiveness Analysis and Discrete Event Simulation Study

Obesity’s Cancer Role Underestimated

A proposed framework highlights potential sources of bias in current estimates